Contains active ingredients including Miconazole
Please sign in to your online account to order OTC medication
Skin Health 1and2 Skin Health Covarex Cream 30g
Scheduling status: S1.Proprietary name (and dosage form):Covarex cream.Composition:Covarex contains:Miconazole nitrate - 2 g per 100 g.Preservatives:Imidurea - 0.2% m/m.Methyl paraben - 0.15% m/m.Sodium propyl paraben - 0.15% m/m.Anti-oxidant:Butyl hydroxytoluene - 0.02% m/m.Pharmacological classification:A 13.9.2 fungicides.Pharmacological action:Miconazole nitrate is a fungistatic. In candida albicans it inhibits transformation of blastospores into invasive mycelial form.Indications:Covarex is indicated in the topical treatment of cutaneous candidiasis caused by candida albicans and of tinea corporis (ringworm of the body), tinea cruris (ringworm of the groin) and tinea pedis (ringworm of the foot) caused by trichophyton rubrum, T. mentagrophytes, and epidermophyton floccosum.Identification:A smooth white to greyish white cream.Presentation:Polyethylene laminated aluminium tubes of 25 g, 30 g, 40 g and 50 g with white screw cap.Marketed by Glenmark Pharmaceuticals South Africa (Pty) Ltd.Date of publication of this package insert:24 August 2007.Use in the topical treatment of cutaneous candidiasis caused by candida albicans and of tinea corporis (ringworm of the body), tinea cruris (ringworm of the groin) and tinea pedis (athlete's foot).
Quantity in pack:
How to use
Store below 25 degrees C and do not freeze.
Contra-indications:Hypersensitivity to miconazole nitrate or any other ingredients of Covarex.For external use only.Continue to apply Covarex for the full period of treatment as indicated under the heading "dosage and directions for use".Side-effects and special precautions:Covarex may cause blistering, burning, redness, skin rash or other sign of skin irritation and contact dermatitis not present before therapy.After prolonged and extensive application, systemic absorption can not be excluded that may result in side-effects usually associated with systemically administered miconazole nitrate such as anaemia, hepatotoxicity, thrombocytopenia, dizziness, drowsiness, headache, flushing or redness of face or skin and gastrointestinal disturbances.Safety of topical use during pregnancy and lactation has not been established.Known symptoms of overdosage and particulars of its treatment:No known symptoms. See "side effects and special precautions". Treatment is symptomatic and supportive.Keep out of the reach of children.